All In MedTech

Device Trial Radar · NCT02927665

A Prospective Multicenter Post Approval Study of the ReShape™ Integrated Dual Balloon System in Obese Subjects

Last checked: Nov 20, 2026Latest source record: Mar 29, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

186

Actual

Start

Sep 2016

Primary completion

Nov 2019

Study completion Dec 2019

Sponsor

Lead sponsor
ReShape LifesciencesNot on our public-company list
Sponsor type
Industry
First posted
Oct 7, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The ReShape Post Approval Study is a prospective multicenter study of the ReShape(TM) Integrated Dual Balloon System in Obese Subjects.

Conditions

  • Obesity

Interventions

  • Reshape Integrated Dual BalloonDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety of ReShape Dual Balloon TreatmentTime frame: 24 weeks

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Digestive Health Specialists of the Southeast

    Dothan, Alabama

  • Christiana Institute of Advanced Surgery

    Newark, Delaware

  • Barrington Surgeons

    Barrington, Illinois

11 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.